Douglas Holtzman, Chief Scientific Officer at Icosavax, Inc. (ICVX), sold 30,617 shares at $8.74 ($269K) on 2023-07-03, disclosed to the SEC on 2023-07-03.
Scheduled sale ($269k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.74 | 14,261 | $125K | 46.3% |
| 2 | $8.74 | 14,261 | $125K | 46.3% |
| 3 | $9.59 | 2,095 | $20K | 7.5% |
| Total | $8.80 avg | 30,617 | $269K | 100% |
| Filing → |
| ICVX | SELL | 2022-12-16 | $438K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $131K | — | Filing → |